E D P Drug and Alcohol Services Revenue and Competitors
Estimated Revenue & Valuation
- E D P Drug and Alcohol Services's estimated annual revenue is currently $6.3M per year.
- E D P Drug and Alcohol Services's estimated revenue per employee is $90,000
Employee Data
- E D P Drug and Alcohol Services has 70 Employees.
- E D P Drug and Alcohol Services grew their employee count by -10% last year.
E D P Drug and Alcohol Services's People
Name | Title | Email/Phone |
---|---|---|
1 | Criminal Justice Community Transitions Worker | Reveal Email/Phone |
E D P Drug and Alcohol Services Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.5M | 168 | 28% | N/A | N/A |
#2 | $48.8M | 390 | 6% | N/A | N/A |
#3 | $27.5M | 250 | 10% | N/A | N/A |
#4 | $24.3M | 221 | 9% | N/A | N/A |
#5 | $27.1M | 246 | 24% | N/A | N/A |
#6 | $7.9M | 79 | 3% | N/A | N/A |
#7 | $8.1M | 81 | 3% | N/A | N/A |
#8 | $3M | 38 | 6% | N/A | N/A |
#9 | $3.9M | 49 | -8% | N/A | N/A |
#10 | $6.5M | 72 | 6% | N/A | N/A |
What Is E D P Drug and Alcohol Services?
EDP Drug & Alcohol Services (EDP) is a charity working primarily in the South West, providing services across Devon and Dorset, in the community and within prisons. We offer a number of dynamic and innovative initiatives which work alongside people to improve their wellbeing, social connections and employability. We are passionate about supporting individuals who face complex issues, including substance misuse, mental ill health, and other harmful, addictive and offending behaviour, to improve their lives. The fundamental belief underpinning our work is that, given the right support and resources, people can and do make remarkable changes.
keywords:N/AN/A
Total Funding
70
Number of Employees
$6.3M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
E D P Drug and Alcohol Services News
A drug dealer who made almost a quarter of a million pounds from his crimes has been ordered to pay back just £4,600.
... 16-fold of that of PBI-0451 and 7-fold of that of EDP-235. ASC11 is an in-house discovered oral small molecule drug candidate,...
Ascletis Pharma has reported that its oral small molecule drug candidate ASC11 ... 16-fold and seven-fold to that of PBI-0451 and EDP-235,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 73 | 813% | N/A |
#2 | $9.9M | 73 | -3% | N/A |
#3 | $10M | 74 | 6% | N/A |
#4 | $17.7M | 78 | -4% | N/A |
#5 | $19.4M | 88 | -7% | N/A |